2 Year Follow up of COSGOD III

CompletedOBSERVATIONAL
Enrollment

417

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 9, 2024

Study Completion Date

December 31, 2024

Conditions
Neurodevelopmental DisabilityDeath
Interventions
OTHER

NIRS group

Standard care plus cerebral oxygen saturation monitoring with a dedicated treatment guideline (NIRS-group) during immediate transition (first 15 minutes after birth) and resuscitation.

Trial Locations (11)

Unknown

Medical University of Graz, Graz

Medical University Innsbruck, Innsbruck

Medical University Vienna, Vienna

University of Alberta, Edmonton

Universitätsklinikum Freiburg, Freiburg im Breisgau

Centre for Ped. Clinical Studies Tübingen, Tübingen

University College Cork, Cork

"Ospedale dei Bambini V.Buzzi Milano", Milan

Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste

Ginekologiczno Położniczy Szpital Kliniczny Uniwersytetu Medycznego im. Karola Marcinkowskiego, Poznan

University Medical Centre Ljubljana, Ljubljana

All Listed Sponsors
collaborator

Medical University Innsbruck

OTHER

collaborator

Medical University of Vienna

OTHER

collaborator

Vittore Buzzi Children's Hospital

OTHER

collaborator

University Hospital Tuebingen

OTHER

collaborator

University College Cork

OTHER

collaborator

University Hospital Freiburg

OTHER

collaborator

Poznan University of Medical Sciences

OTHER

collaborator

University Medical Centre Ljubljana

OTHER

collaborator

IRCCS Burlo Garofolo

OTHER

collaborator

University of Alberta

OTHER

lead

Medical University of Graz

OTHER

NCT06141733 - 2 Year Follow up of COSGOD III | Biotech Hunter | Biotech Hunter